Kazakh Institute of Oncology and Radiology. Almaty, Kazakhstan.
S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Asian Pac J Cancer Prev. 2021 Feb 1;22(2):581-589. doi: 10.31557/APJCP.2021.22.2.581.
Up to date, there no studies were conducted on the quality of life (QL) and sexual function (SF) of women from Kazakhstan treated for cervical cancer. The study was aimed at the assessment of the QL and SF of women of the Kazakh population who underwent radical hysterectomy compared with chemo-radiotherapy group.
The study was conducted prospectively on 157 women of the Kazakh population. 92 women underwent radical hysterectomy (RH) and 65 underwent chemo-radiotherapy (CRT). The information was collected before treatment (T1), 6 months (T2) and 12 months (T3) after treatment.
The women's average age was 41.12 ± 5.4 in the RH group and 47.24 ± 6.1 in the CRT group (p = 0.2). We did not detect significant differences between both groups according to the QLQ C-30 questionnaire (T1). The differences between the RH and CRT groups (p≤0,05) were observed in terms of physical functioning, fatigue, nausea and vomiting, pain during the T2 period. High rates of emotional functioning (p = 0.03), global health and QL (p = 0.02), and symptoms of fatigue (p = 0.04) were detected in the RH group compared to the CRT group during T3. However, pain symptoms (p = 0.001), nausea and vomiting and loss of appetite (p = 0.03) were dominated the CRT group. According to the results of FSFI-6 in the RH group, indicators for the domains "desire" (p = 0.02), "excitement" (p = 0.03), and "orgasm" (p = 0.05) were high, unlike in the CRT group during the T3 period. Nevertheless, the number of complains on the 'pain during intercourse' in the CRT group was higher than in the RH group (p = 0.001).
Women who underwent RH had better health scores, global health status, and SF compared with patients treated with CRT.
目前,针对哈萨克斯坦接受宫颈癌治疗的女性的生活质量(QL)和性功能(SF),尚未有研究。本研究旨在评估哈萨克族女性接受根治性子宫切除术(RH)与放化疗(CRT)后的 QL 和 SF。
本前瞻性研究纳入了 157 名哈萨克族女性。其中 92 例行 RH,65 例行 CRT。在治疗前(T1)、治疗后 6 个月(T2)和 12 个月(T3)采集信息。
RH 组女性的平均年龄为 41.12 ± 5.4 岁,CRT 组为 47.24 ± 6.1 岁(p = 0.2)。根据 QLQ C-30 问卷,两组在 T1 时没有显著差异。在 T2 期间,RH 组和 CRT 组在身体功能、疲劳、恶心和呕吐、疼痛方面存在差异(p≤0.05)。在 T3 期间,RH 组的情绪功能(p = 0.03)、总体健康状况和生活质量(p = 0.02)以及疲劳症状(p = 0.04)较高,而 CRT 组则以疼痛症状(p = 0.001)、恶心和呕吐以及食欲不振(p = 0.03)为主。根据 RH 组 FSFI-6 的结果,“欲望”(p = 0.02)、“兴奋”(p = 0.03)和“高潮”(p = 0.05)领域的指标较高,而 CRT 组在 T3 期间则不同。然而,CRT 组报告“性交疼痛”的人数多于 RH 组(p = 0.001)。
与 CRT 治疗的患者相比,接受 RH 的女性在健康评分、总体健康状况和 SF 方面表现更好。